Agilent Feb 23, 2026 Agilent Technologies (A) Stock Analysis: A Promising 38% Upside In The Healthcare Sector - DirectorsTalk Interviews
Waters Feb 23, 2026 Waters Corporation (WAT) Stock Analysis: Unlocking 19.42% Potential Upside in the Healthcare Diagnostics Sector - DirectorsTalk Interviews
Illumina Feb 23, 2026 Illumina, Inc. (ILMN) Stock Analysis: Exploring a 15.62% Potential Upside in the Genomics Sector - DirectorsTalk Interviews
BioPharma Dive Feb 23, 2026 Novo’s next-gen obesity shot fails to match Lilly drug in head-to-head study
Endpoints News Feb 23, 2026 FDA unveils long-awaited guidance on new pathway for individualized therapies
Endpoints News Feb 23, 2026 AbbVie budgets $380M for obesity and neuroscience API facilities in Chicago
Endpoints News Feb 23, 2026 A federal experiment opens up a new market for digital health — if it works